
SKIN Stock Forecast & Price Target
SKIN Analyst Ratings
Bulls say
SkinHealth Systems is well positioned for long-term success, despite facing competitive pressures and ongoing legal obligations, given its strong niche in the non-invasive medical aesthetics market with its Hydrafacial brand. The company's recent financial results exceeded expectations, and the new CEO is taking proactive steps to manage the sales organization and develop new products. However, potential impediments to our price target include softening equipment demand and one-time expenses related to litigation and restructuring that may affect cash flow in the short term.
Bears say
SkinHealth Systems is facing several challenges that have resulted in a negative outlook for its stock. These include lowered revenue guidance for 2026, expiration of key patents, intense competition in the beauty industry, and declining consumable sales. Despite a strong 4Q performance, the company still faces challenges in its device sales and utilization, and it may take time to see consistent improvements. Additionally, macroeconomic factors and the company's heavy reliance on the Hydrafacial platform pose risks to its growth. These challenges may make it difficult for SkinHealth Systems to expand its customer base and sustain its brand awareness, leading to a negative outlook on the stock.
This aggregate rating is based on analysts' research of The Beauty Health Company and is not a guaranteed prediction by Public.com or investment advice.
SKIN Analyst Forecast & Price Prediction
Start investing in SKIN
Order type
Buy in
Order amount
Est. shares
0 shares